Showing results (1-10 of 648) with videos related to

Sort By:
Pageof 65
Cell Communication and Signaling : CCS|April 12, 2023
Recent advances and future challenges of tumor vaccination therapy for recurrent glioblastomaBinghao Zhao, Jiaming Wu, Huanzhang Li, et al.
Pharmacological Research|June 20, 2022
Comparative efficacy and safety of therapeutics for elderly glioblastoma patients: A Bayesian network analysisBinghao Zhao, Jiaming Wu, Yu Xia, et al.
Pharmacological Research|October 9, 2021
A Bayesian network meta-analysis regarding the comparative efficacy of therapeutics for ALK-positive, brain metastatic non-small cell lung cancerBinghao Zhao, Yan Han, Yadong Wang, et al.
Journal of Hematology & Oncology|October 26, 2022
Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapyBinghao Zhao, Huanzhang Li, Yu Xia, et al.
Frontiers in Immunology|July 5, 2021
Investigation of Genetic Determinants of Glioma Immune Phenotype by Integrative Immunogenomic Scale AnalysisBinghao Zhao, Yuekun Wang, Yaning Wang, et al.
Cancer Medicine|October 13, 2020
Development of a nomogram for prognostic prediction of lower-grade glioma based on alternative splicing signaturesYaning Wang, Zihao Wang, Binghao Zhao, et al.
Epilepsy & Behavior : E&B|November 2, 2024
Genetic association between epilepsy and gliomas: Insights from Mendelian randomization and single-cell transcriptomic analysesLiguo Ye, Hao Xing, Yu Wang, et al.
Frontiers in Oncology|April 15, 2021
Optimal Therapies for Recurrent Glioblastoma: A Bayesian Network Meta-AnalysisWenlin Chen, Yuekun Wang, Binghao Zhao, et al.
Frontiers in Oncology|December 30, 2022
Palliative care for patients with glioma: A recent scientometric analysis of the Web of Science in 2022Zhiyuan Xiao, Wenlin Chen, Haiyan Zhao, et al.
Molecular Medicine (Cambridge, Mass.)|March 15, 2022
Molecular landscape of IDH-mutant astrocytoma and oligodendroglioma grade 2 indicate tumor purity as an underlying genomic factorBinghao Zhao, Yu Xia, Fengchun Yang, et al.
Pageof 65